Search results
Big Pharma Is Hijacking the Information Doctors Need Most
Time via Yahoo News· 2 years agoBack in 1982, when I first began my career as a family practitioner in a small town of Boston, I was...
Merck's CEO to succeed Ken Frazier as chairman
Reuters via Yahoo Finance· 1 year agoFrazier, who has been a key growth driver of the drugmaker for decades, joined Merck around 30 years ago and became the first Black CEO of a major drug...
Opinion: How climate research is polluted by fossil fuel money — and how to fix it
LA Times via Yahoo News· 5 months agoMedicine has conflict of interest policies that, while imperfect, help lessen the influence of...
Drugmakers' shares stabilise after Zantac litigation slump
Reuters via Yahoo Finance· 2 years agoShares in GSK, Sanofi, Haleon and Pfizer began to recover on Friday after the companies said that...
Top FDA official Woodcock to retire early next year
BioPharma Dive via Yahoo Finance· 5 months agoThe 37-year veteran helmed the agency’s pandemic response, and was a key decision-maker in controversial calls on opioids, an Alzheimer's therapy and...
Haleon believes it is not liable for any potential Zantac liabilities
Reuters via Yahoo Finance· 2 years agoLONDON (Reuters) -Haleon believes it is not liable for any claims that may arise from U.S....
GSK, Sanofi shares soar as Zantac litigation fears abate
Reuters via Yahoo Finance· 1 year agoShares of GSK and Sanofi surged on Wednesday, adding more than $20 billion in combined value in...
GSK, Sanofi and Haleon shares slump on Zantac litigation concerns
Reuters via Yahoo News· 2 years agoLONDON (Reuters) -Shares in GSK, Sanofi and Haleon fell sharply on Thursday, following declines...
New GSK maintains strong start, but Zantac litigation looms large
Reuters via Yahoo Finance· 1 year ago(Reuters) -GSK raised its 2022 forecast for the second time this year, after third-quarter earnings...
Should You Consider Acquiring Bayer (BAYRY) Shares?
Insider Monkey via Yahoo Finance· 2 years agoMittleman Brothers Investment Management, an investment management firm, published its first-quarter 2022 investor letter – a copy of which can be...
